Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors have?
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors has 57 citations in the OpenAlex counts ScholarIQ stores.
When was Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors published?
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors has 2021 year in the ScholarIQ index.
What is the open-access status of Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors?
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors has green oa status in the ScholarIQ index.
What is the DOI of Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors?
The DOI for Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors is on the source record.
What is the PMID of Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors?
The PMID for Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors is on the source record.
What is the OpenAlex record for Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors?
The OpenAlex for Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors is on the source record.